Συγγραφείς:
Breza, M.
Koutsis, G.
Tzartos, J.S.
Velonakis, G.
Evangelopoulos, M.E.
Tzanetakos, D.
Karagiorgou, K.
Angelopoulou, G.
Kasselimis, D.
Potagas, C.
Anagnostouli, M.
Stefanis, L.
Kilidireas, C.
Λέξεις-κλειδιά:
biological marker; complement; immunoglobulin G; immunoglobulin G1 antibody; myelin oligodendrocyte glycoprotein antibody; protein antibody; unclassified drug; immunoglobulin G; myelin oligodendrocyte glycoprotein, antibody titer; antigen specificity; brain damage; cell assay; clinical feature; conus medullaris; corpus callosum; demyelinating disease; disease association; false positive result; human; immunoassay; Letter; multiple sclerosis; nuclear magnetic resonance imaging; patient care; phenotype; prognosis; demyelinating disease, Demyelinating Diseases; Humans; Immunoglobulin G; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein